Prevalence, Management, and Outcomes of Non-Invasive Helicobacter pylori Testing in Children at a Tertiary Paediatric

Charanya Rajan1, Fang Kuan Chiou1, Christopher Wen Wei Ho1

  • 1Division of Gastroenterology, Hepatology and Nutrition Service, Department of Paediatric Medicine, KK Women's and Children's Hospital, Singapore, Singapore.

Insights

Pediatric H. pylori testing often uses a test-and-treat approach, deviating from guidelines. This study found high treatment rates and varied outcomes in children undergoing non-invasive H. pylori diagnosis.

Area of Science:

  • Pediatric Gastroenterology
  • Infectious Diseases
  • Clinical Practice Guidelines

Background:

  • Helicobacter pylori infections present differently in pediatric versus adult populations.
  • Current pediatric practice guidelines advise against a test-and-treat strategy for H. pylori diagnosis.
  • Clinical practice often deviates from established guidelines, necessitating an examination of current approaches.

Purpose of the Study:

  • To investigate the utilization of non-invasive H. pylori testing (stool antigen, urea breath test) in children.
  • To analyze management decisions and patient outcomes following H. pylori diagnosis in a pediatric tertiary hospital.
  • To assess adherence to clinical guidelines regarding H. pylori management in pediatric patients.

Main Methods:

  • A retrospective review of pediatric patients (0-18 years) tested for H. pylori via stool antigen or urea breath test (UBT) from January 2018 to June 2020.
  • Analysis of diagnostic test results, symptoms, treatment regimens, and symptom resolution.
  • Comparison of testing and treatment strategies against existing pediatric practice guidelines.

Main Results:

  • 1,397 children were tested; 8.4% had positive stool antigen tests and 5.9% had positive UBTs.
  • Abdominal pain was the most common symptom (80.3%). Only 7 treatment-naïve children had biopsy-proven disease.
  • 91.0% of children received treatment, with a common regimen of PPI, amoxicillin, and clarithromycin; 50.8% experienced symptom resolution.

Conclusions:

  • A test-and-treat strategy was frequently employed, indicating low compliance with pediatric H. pylori management guidelines.
  • Non-invasive testing in children revealed a notable rate of false positives.
  • The study highlights discrepancies between recommended guidelines and actual clinical practice in diagnosing and treating H. pylori in pediatric populations.
Abstract

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
328
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
89
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
74
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
158
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
54
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
231